Genetic characteristics predict response to venetoclax plus hypomethylating agents in relapsed or refractory acute myeloid leukemia.

Journal of internal medicine(2023)

Cited 10|Views37
No score
Abstract
VEN combined with HMA was effective with R/R AML patients, and the response to treatment was associated with genetic characteristics.
More
Translated text
Key words
genetic characteristics,hypomethylating agents,relapsed or refractory AML,venetoclax
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined